Synopsis
Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 2-((cyclohexylhydroxyphenylacetyl)oxy)-n,n-diethyl-n-methylethanaminium
2. Atrenyl
3. Bromide, Oxyphenonium
4. Chloride, Oxyphenonium
5. Iodide, Oxyphenonium
6. Metacin
7. Methacin
8. Oxyphenon
9. Oxyphenonium
10. Oxyphenonium Bromide, (+)-isomer
11. Oxyphenonium Bromide, (+-)-isomer
12. Oxyphenonium Bromide, (-)-isomer
13. Oxyphenonium Chloride
14. Oxyphenonium Iodide
15. Oxyphenonium Iodide, (r)-isomer
16. Oxyphenonium Iodide, (s)-isomer
17. Oxyphenonium, (+-)-isomer
18. Oxyphenonium, (r)-isomer
19. Oxyphenonium, (s)-isomer
20. Spastrex
1. 50-10-2
2. Spasmophen
3. Oxifenon
4. Oxyfenon
5. Oxyphenon
6. Antrenyl
7. Oxyphenoniumbromide
8. Antrenil
9. Spasmodin
10. Ba-5473
11. Oxyphenonium (bromide)
12. Nsc-759248
13. Mls000028620
14. S9421hwb3z
15. 2-(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxyethyl-diethyl-methylazanium;bromide
16. Smr000058660
17. Subranyl
18. Antrenyl Bromide
19. C-5473
20. Oxyphenonium Bromide (inn)
21. Dsstox_cid_25632
22. Dsstox_rid_81014
23. Ethanaminium, 2-((cyclohexylhydroxyphenylacetyl)oxy)-n,n-diethyl-n-methyl-, Bromide
24. Dsstox_gsid_45632
25. Oxyphenonium Bromide [inn]
26. Cas-50-10-2
27. Oxyphenonii Bromidum
28. Bromuro De Oxifenonio
29. Bromure D'oxyphenonium
30. Oxyphenonium Bromide [inn:ban]
31. Oxyphenonii Bromidum [inn-latin]
32. Ncgc00018256-02
33. Einecs 200-010-7
34. Bromure D'oxyphenonium [inn-french]
35. Bromuro De Oxifenonio [inn-spanish]
36. Unii-s9421hwb3z
37. C 5473
38. Antrenyl (tn)
39. Opera_id_1635
40. Diethyl(2-hydroxyethyl)methylammonium Bromide Alpha-phenylcyclohexaneglycolate
41. Regid_for_cid_5748
42. Mls001076268
43. Mls001424168
44. Schembl248890
45. Chembl1200906
46. Dtxsid4045632
47. Oxyphenonium Bromide [mi]
48. Hms2052o07
49. Hms2230j18
50. Hms3371m04
51. Hms3394o07
52. Pharmakon1600-01505783
53. (+/-)-oxyphenonium Bromide
54. Oxyphenonium Bromide [vandf]
55. Tox21_110851
56. Nsc759248
57. Oxyphenonium Bromide [mart.]
58. Oxyphenonium Bromide [who-dd]
59. Akos030507607
60. Tox21_110851_1
61. Ccg-101094
62. Ccg-213986
63. Nc00344
64. Ammonium, Diethyl(2-hydroxyethyl)methyl-, Bromide, Alpha-phenylcyclohexaneglycolate
65. Ncgc00018256-06
66. Oxyphenonium Bromide [orange Book]
67. D06877
68. Sr-01000003140
69. Q7116109
70. Sr-01000003140-4
71. Z1551429731
72. {2-[(2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxy]ethyl}diethylmethylazanium Bromide
73. 2-(2-cyclohexyl-2-hydroxy-2-phenylacetoxy)-n,n-diethyl-n-methylethan-1-aminium Bromide
74. Diethyl(2-hydroxyethyl)methylammonium Bromide .alpha.-phenylcyclohexaneglycolate
75. Ethanaminium, 2-((2-cyclohexyl-2-hydroxy-2-phenylacetyl)oxy)-n,n-diethyl-n-methyl-, Bromide (1:1)
Molecular Weight | 428.4 g/mol |
---|---|
Molecular Formula | C21H34BrNO3 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 9 |
Exact Mass | 427.17221 g/mol |
Monoisotopic Mass | 427.17221 g/mol |
Topological Polar Surface Area | 46.5 Ų |
Heavy Atom Count | 26 |
Formal Charge | 0 |
Complexity | 409 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 1 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
Mydriatics
Agents that dilate the pupil. They may be either sympathomimetics or parasympatholytics. (See all compounds classified as Mydriatics.)
Muscarinic Antagonists
Drugs that bind to but do not activate MUSCARINIC RECEPTORS, thereby blocking the actions of endogenous ACETYLCHOLINE or exogenous agonists. Muscarinic antagonists have widespread effects including actions on the iris and ciliary muscle of the eye, the heart and blood vessels, secretions of the respiratory tract, GI system, and salivary glands, GI motility, urinary bladder tone, and the central nervous system. (See all compounds classified as Muscarinic Antagonists.)
Parasympatholytics
Agents that inhibit the actions of the parasympathetic nervous system. The major group of drugs used therapeutically for this purpose is the MUSCARINIC ANTAGONISTS. (See all compounds classified as Parasympatholytics.)
ABOUT THIS PAGE
A Oxyphenonium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Oxyphenonium, including repackagers and relabelers. The FDA regulates Oxyphenonium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Oxyphenonium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Oxyphenonium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Oxyphenonium supplier is an individual or a company that provides Oxyphenonium active pharmaceutical ingredient (API) or Oxyphenonium finished formulations upon request. The Oxyphenonium suppliers may include Oxyphenonium API manufacturers, exporters, distributors and traders.
click here to find a list of Oxyphenonium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
Oxyphenonium Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Oxyphenonium GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Oxyphenonium GMP manufacturer or Oxyphenonium GMP API supplier for your needs.
A Oxyphenonium CoA (Certificate of Analysis) is a formal document that attests to Oxyphenonium's compliance with Oxyphenonium specifications and serves as a tool for batch-level quality control.
Oxyphenonium CoA mostly includes findings from lab analyses of a specific batch. For each Oxyphenonium CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Oxyphenonium may be tested according to a variety of international standards, such as European Pharmacopoeia (Oxyphenonium EP), Oxyphenonium JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Oxyphenonium USP).
LOOKING FOR A SUPPLIER?